Monopar Therapeutics

Nasdaq:MNPR

Pharmaceutical Preparations·WILMETTE, IL

CEO

Robinson Chandler

CFO

Vu Quan Anh

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/8/24	→
10-Q	Q2 2024	6/30/24	8/9/24	→
↓

Earnings Releases (8-K)

18 shown

Filed	Period
11/13/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/31/25	Q1 FY2025	→
11/8/24	Q4 FY2024	→
8/9/24	Q3 FY2024	→
↓

News (8-K)

62 shown

Filed	Type	Description
3/2/26	Reg FD	Regulation FD Disclosure	→
11/10/25	Reg FD	Regulation FD Disclosure	→
9/24/25	Agreement	Entry into a Material Definitive Agreement	→
9/15/25	Reg FD	Regulation FD Disclosure	→
6/23/25	Vote	Submission of Matters to a Vote of Security Holders	→
5/7/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

30 shown

Filed	Form	Description
9/24/25	424B5	424B5	→
8/29/25	S-3	S-3	→
5/12/25	ARS	ARS	→
3/31/25	S-8	S-8	→
1/27/25	424B3	424B3	→
1/15/25	S-3	S-3	→
↓

Filing History(482 filings)

TypeDateAccessionPeriodSize

Mar 4, 2026

0001437749-26-006935FORM 4

Mar 2, 2026

4.8 KB

Mar 4, 2026

0001437749-26-006934FORM 3

Mar 2, 2026

6.9 KB

8-K

Mar 2, 2026

0001437749-26-006229FORM 8-K

Mar 2, 2026

177.1 KB

SCHEDULE 13G/A

Feb 17, 2026

0001346824-26-000051

—

14.9 KB

SCHEDULE 13G/A

Feb 6, 2026

0001104659-26-011303

—

9.6 KB

SCHEDULE 13D/A

Jan 30, 2026

0001437749-26-002528

—

9.7 KB

Jan 30, 2026

0001437749-26-002527FORM 4

Jan 28, 2025

5.3 KB

Jan 5, 2026

0001437749-26-000306FORM 4

Dec 31, 2025

10.5 KB

Jan 5, 2026

0001437749-26-000305FORM 4

Dec 31, 2025

9.4 KB

Jan 5, 2026

0001437749-26-000304FORM 4

Jan 1, 2026

4.9 KB

Dec 29, 2025

0001437749-25-038804FORM 4

Dec 26, 2025

4.0 KB

144

Dec 19, 2025

0001628280-25-058223

—

4.1 KB

Dec 19, 2025

0001437749-25-038426FORM 4

Dec 18, 2025

6.3 KB

Dec 17, 2025

0001437749-25-038139FORM 4

Dec 16, 2025

6.1 KB

Dec 17, 2025

0001437749-25-038138FORM 4

Dec 16, 2025

4.2 KB

Dec 8, 2025

0001437749-25-037171FORM 4

Dec 2, 2025

6.9 KB

Dec 8, 2025

0001437749-25-037170FORM 4

Dec 2, 2025

4.8 KB

Dec 8, 2025

0001437749-25-037169FORM 4

Dec 2, 2025

4.8 KB

Dec 8, 2025

0001437749-25-037168FORM 4

Dec 2, 2025

4.8 KB

Dec 8, 2025

0001437749-25-037167FORM 4

Dec 2, 2025

4.8 KB

Dec 8, 2025

0001437749-25-037165FORM 4

Dec 2, 2025

4.8 KB

Dec 8, 2025

0001437749-25-037164FORM 4

Dec 2, 2025

6.8 KB

Dec 8, 2025

0001437749-25-037163FORM 4

Dec 2, 2025

6.9 KB

SCHEDULE 13G/A

Nov 14, 2025

0001231919-25-000489

—

15.1 KB

SCHEDULE 13G/A

Nov 14, 2025

0001274173-25-000317

—

10.4 KB

25 filings shown

Filed	Form	Description
5/23/25	DEFA14A	FORM DEFA14A	→
4/30/25	DEF 14A	DEF 14A	→
7/22/24	DEF 14A	DEF 14A	→
7/11/24	PRE 14A	FORM PRE 14A	→
4/28/23	DEFA14A	DEFA 14A	→
4/28/23	DEF 14A	DEF 14A	→
↓

Monopar Therapeutics

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(482 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/4/26	4	4	→
3/4/26	3	FORM 3	→
1/30/26	4	4	→
1/5/26	4	4	→
1/5/26	4	4	→
1/5/26	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/6/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/30/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
12/19/25	144	144	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓